- Home
- TARA vs CYBN Comparison
TARA vs CYBN Comparison
Compare TARA & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- CYBN
- Stock Information
- Founded
- TARA N/A
- CYBN 2019
- Country
- TARA United States
- CYBN Canada
- Employees
- TARA N/A
- CYBN N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- CYBN Pharmaceuticals and Biotechnology
- Sector
- TARA Health Care
- CYBN Health Care
- Exchange
- TARA Nasdaq
- CYBN Nasdaq
- Market Cap
- TARA 202.8M
- CYBN 177.9M
- IPO Year
- TARA N/A
- CYBN N/A
- Fundamental
- Price
- TARA $4.55
- CYBN $9.13
- Analyst Decision
- TARA Strong Buy
- CYBN Strong Buy
- Analyst Count
- TARA 3
- CYBN 3
- Target Price
- TARA $22.67
- CYBN $138.00
- AVG Volume (30 Days)
- TARA 523.2K
- CYBN 213.0K
- Earning Date
- TARA 03-12-2025
- CYBN 02-12-2025
- Dividend Yield
- TARA N/A
- CYBN N/A
- EPS Growth
- TARA N/A
- CYBN N/A
- EPS
- TARA N/A
- CYBN N/A
- Revenue
- TARA N/A
- CYBN N/A
- Revenue This Year
- TARA N/A
- CYBN N/A
- Revenue Next Year
- TARA N/A
- CYBN N/A
- P/E Ratio
- TARA N/A
- CYBN N/A
- Revenue Growth
- TARA N/A
- CYBN N/A
- 52 Week Low
- TARA $1.60
- CYBN $6.50
- 52 Week High
- TARA $10.48
- CYBN $19.84
- Technical
- Relative Strength Index (RSI)
- TARA 41.78
- CYBN 45.18
- Support Level
- TARA $5.04
- CYBN $8.83
- Resistance Level
- TARA $6.20
- CYBN $9.41
- Average True Range (ATR)
- TARA 0.40
- CYBN 0.59
- MACD
- TARA -0.22
- CYBN -0.02
- Stochastic Oscillator
- TARA 2.37
- CYBN 31.74
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.